Steris (NYSE:STE) and Synergy Health postponed their shareholders meetings to give a U.S. court time to rule on the Federal Trade Commission’s bid to halt their $1.9 billion merger. Mentor, Ohio-based Steris said it moved its meeting from Sept. 24 to Oct. 2; Synergy plans to hold its vote the same day, according to a regulatory filing. Earlier […]
Steris Corp.
FTC says evidence exists to block $2B Steris-Synergy buy
The Federal Trade Commission said it has evidence showing Synergy Health was ready to bring new technology to the U.S. sterilization market before Steris (NYSE:STE) offered $1.9 billion to purchase the company, and is seeking seeking an injunction to block the deal. The FTC claims Synergy was fully vested in a plan to expand into x-ray sterilization […]
Judge lifts System 1 consent decree against Steris
Steris (NYSE:STE) said today that a federal judge lifted a 5-year-old consent decree covering its now-discontinued System 1 endoscope sterilization device. Mentor, Ohio-based Steris’s System 1 landed in “violating device” status in December 2009, after 18 months of legal wrangling with the FDA that ended in the de facto recall of a product that hadn’t been linked to any […]
Steris drops $226m on General Econopak, Black Diamond Video
Steris (NYSE:STE) today said it agreed to pay $226 million to acquire a medical sterilization company and an operating room integration provider. Mentor, Ohio-based Steris said it agreed to put up $175 million for Philadelphia-based General Econopak, which makes sterility maintenance, barrier protection and sterile cleanroom products. Steris also said it paid $51 million for Black Diamond Video, which […]
Steris, Synergy delay merger vote over FTC request
Appeals court upholds Steris-Medtrica win over Cygnus Medical
U.K. OKs $2B Steris-Synergy merger | The week in medtech M&A
FTC wants more from Steris, Synergy on inversion merger
EPA advisory panel’s ruling could disrupt medtech
A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog’s determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.
If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.